Abstract
Antiviral drug therapy can effectively suppress HIV replication, but emerging viral resistance and drug toxicity limit long-term therapeutic efficacy. In addition, regeneration of the T helper cell repertoire is often incomplete. The current major challenges in the treatment of HIV infection are therefore the reconstitution of cellular immunity, and especially of the HIV-specific immune response, and the suppression of virus replication in patients with HAART failure. Several gene therapeutic strategies for immune reconstitution of AIDS patients have been described. Preclinical and clinical studies have examined the safety and efficacy of two basic approaches: firstly, the transfer of autologous T cells armed with recombinant receptors that target HIV antigens to specifically increase antiviral immunity and, secondly, the transfer of genetically modified T cells or hematopoietic progenitor cells that express an antiviral gene. However, for both approaches, engraftment levels of gene-modified cells have not been sufficient to reconstitute cellular immunity and to effectively reduce the overall viral load in patients. Strategies to improve the technologies and procedures involved in gene therapeutic immune reconstitution of AIDS patients are discussed.
Keywords: HIV infection, stem cell transplantation, T cell therapy, immune reconstitution
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Gene Therapeutic Approaches for Immune Modulation in AIDS
Volume: 6 Issue: 2
Author(s): Dorothee von Laer, Christopher Baum, Axel Schambach, Klaus Kuhlcke, Roland Zahn, Sebastian Newrzela, Jan van Lunzen, R. Paul Johnson and Jorn E. Schmitz
Affiliation:
Keywords: HIV infection, stem cell transplantation, T cell therapy, immune reconstitution
Abstract: Antiviral drug therapy can effectively suppress HIV replication, but emerging viral resistance and drug toxicity limit long-term therapeutic efficacy. In addition, regeneration of the T helper cell repertoire is often incomplete. The current major challenges in the treatment of HIV infection are therefore the reconstitution of cellular immunity, and especially of the HIV-specific immune response, and the suppression of virus replication in patients with HAART failure. Several gene therapeutic strategies for immune reconstitution of AIDS patients have been described. Preclinical and clinical studies have examined the safety and efficacy of two basic approaches: firstly, the transfer of autologous T cells armed with recombinant receptors that target HIV antigens to specifically increase antiviral immunity and, secondly, the transfer of genetically modified T cells or hematopoietic progenitor cells that express an antiviral gene. However, for both approaches, engraftment levels of gene-modified cells have not been sufficient to reconstitute cellular immunity and to effectively reduce the overall viral load in patients. Strategies to improve the technologies and procedures involved in gene therapeutic immune reconstitution of AIDS patients are discussed.
Export Options
About this article
Cite this article as:
von Laer Dorothee, Baum Christopher, Schambach Axel, Kuhlcke Klaus, Zahn Roland, Newrzela Sebastian, van Lunzen Jan, Paul Johnson R. and Schmitz E. Jorn, Gene Therapeutic Approaches for Immune Modulation in AIDS, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598081
DOI https://dx.doi.org/10.2174/187152307780598081 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer
Recent Patents on Anti-Cancer Drug Discovery Membrane Targeted Anticancer Drugs: Potent Inducers of Apoptosis and Putative Radiosensitisers
Current Medicinal Chemistry - Anti-Cancer Agents ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy
Current Pharmaceutical Design Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options
Current Cancer Drug Targets General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets (Discontinued) Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Medical and Dental Implications of Down Syndrome: A Review Part 1: General and Craniofacial Characteristic
Applied Clinical Research, Clinical Trials and Regulatory Affairs Methotrexate-Induced Pneumonitis: Heterogeneity of Bronchoalveolar Lavage and Differences between Cancer and Rheumatoid Arthritis
Inflammation & Allergy - Drug Targets (Discontinued) A Facile “Click Chemistry” Approach to Novel Flavonol Glycoconjugates and Their Cytotoxic Activity
Letters in Organic Chemistry Insect Peptides – Perspectives in Human Diseases Treatment
Current Medicinal Chemistry How Much Gets there and What Does it Do?: The Need for Better Pharmacokinetic and Pharmacodynamic Endpoints in Contemporary Drug Discovery and Development
Current Pharmaceutical Design Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology Targeting Gene Therapy for Prostate Cancer
Current Pharmaceutical Design In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry Characteristics of Brain Tumor Stem Cells and the Rationale for Applying Tyrosine Kinase Inhibitors as Potential Targeting Agents
Recent Patents on Regenerative Medicine Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles
Anti-Cancer Agents in Medicinal Chemistry Caffeic Acid Phenethyl Ester Effects: In Silico Study of its Osteoimmunological Mechanisms
Letters in Drug Design & Discovery Hepatitis C Virus Infection and Antiviral Treatment in Marginal Zone Lymphomas
Current Clinical Pharmacology